Form 4: Intuitive Surgical Exec's Routine Stock Transactions

Intuitive Surgical's SVP & Chief Manufacturing and Supply Chain, Mark Brosius, reported the vesting and acquisition of common stock and restricted/performance stock units, alongside tax-related dispositions.

Summary

• Mark Brosius, SVP & Chief Manufacturing and Supply Chain at Intuitive Surgical Inc. (ISRG), reported multiple transactions on February 26, 2026.
• Acquired 1,622 shares of common stock upon the vesting of Restricted Stock Units (RSUs) at a price of $0.0.
• Disposed of 805 shares of common stock at $506.17 to cover statutory tax withholding requirements related to RSU vesting.
• Acquired 973 shares of common stock upon the vesting of additional RSUs at a price of $0.0.
• Disposed of 483 shares of common stock at $506.17 for statutory tax withholding related to RSU vesting.
• Acquired 2,793 Performance Stock Units (PSUs) initially granted on February 28, 2023, for which performance criteria have been achieved, vesting on February 28, 2026.
• Acquired 1,622 Restricted Stock Units (RSUs) granted on February 26, 2024, which vest 25% annually over four years.
• Acquired 973 Restricted Stock Units (RSUs) granted on February 26, 2025, which vest 25% annually over four years.
• Acquired 4,928 Restricted Stock Units (RSUs) granted on February 26, 2026, which vest 25% annually over four years.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction reflecting scheduled executive compensation and the achievement of performance targets for PSUs, which is generally a positive sign for executive performance.

Positives

• Achievement of performance criteria for 2,793 Performance Stock Units (PSUs) indicates strong company or individual performance.
• Continued vesting and granting of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) suggests ongoing executive compensation and retention.

Negatives

• Disposition of 1,288 shares (805 + 483) of common stock at $506.17 to cover tax obligations, reducing direct beneficial ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive compensation and ownership changes. These transactions are specific to an individual executive's compensation plan and do not typically reflect broader industry trends or company-wide strategic shifts.

Comparison to Industry Standards

• Form 4 is an individual transaction report, not suitable for direct comparison to industry-wide financial benchmarks.
• Executive compensation structures involving RSUs and PSUs are standard practice in the medical device and technology sectors, similar to companies like Medtronic or Stryker, aiming to align executive incentives with long-term shareholder value.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and ownership, indicating alignment of executive interests with company performance through equity awards. The tax-related sales are a common, expected event.
• Employees: Reflects standard executive compensation practices within the company.

Next Steps

• Continued vesting of remaining Restricted Stock Units (RSUs) according to their respective schedules.
• Ongoing service of the reporting person to the Issuer for future vesting events.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, including the vesting of stock units and subsequent tax-related share dispositions. It does not contain new information regarding the company's operational performance, strategic direction, or financial health that would alter an investment thesis. Therefore, a "hold" recommendation is appropriate as this filing provides transparency but no material catalyst for a change in stock valuation.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Units, Restricted Stock Units, Performance Stock Units, Executive Compensation, Stock Vesting, Mark Brosius